Clinical Trial

Hypofractionated Radiation Therapy vs Standard Treatment in Breast Cancer.

Active, Not Recruiting
View on ClinicalTrials.gov →
Summary
An explanatory study comparing complementary treatment to breast conservative surgery with radiation therapy DCIS, T1-T2 N0 M0 (AJCC v8) 1 week schedule vs 3.1 weeks standard schedule, in order to determine the equivalence of local tumor control, survival, acute and chronic toxicity. Shorter curse of radiation therapy may lead to similar local control of tumor cells and lower rates of toxicity than 3.1 standard treatment.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2022-03-31; most recent amendment 2026-03-19.
Status change: Recruiting → Active, Not Recruiting 2026-03-19
Trial Details
NCT Number NCT05318274
Lead Sponsor Coordinación de Investigación en Salud, Mexico
Conditions Ductal Breast Carcinoma in Situ, Invasive Breast Cancer, Early-stage Breast Cancer, Stage 0 Breast Cancer, Stage I Breast Cancer, Stage IA Breast Cancer, Stage IB Breast Cancer
Enrollment 72 participants
Start Date 2021-04-26
Primary Completion 2026-12-30 (estimated)
Study Completion 2026-12-30 (estimated)
Updated on ClinicalTrials.gov 2026-03-23